Interestingly, the variants in PPARG, ADIPOQ, and ENPP1, which elevate risk in obese populations, have been categorized as acting on insulin resistance while the TCF7L2 variant elevating risk in lean populations has been categorized as acting on insulin secretion [14-17]. This evidence concerns the gene ENPP1 and Insulin resistance.